BURFORD SURGERY — All Prescriptions & Medications — Page 11
Practice Code: K84047 | BURFORD, OX18 4LS
Showing results 501-550 of 560
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Entacapone | 13 | 1,620 | £367 | -14.7% ▼ |
| Naltrexone hydrochloride | 13 | 364 | £1.0K | -8.4% ▼ |
| Sodium fluoride | 13 | 1,989 | £241 | -60.8% ▼ |
| Calcitriol | 13 | 390 | £68 | -16.7% ▼ |
| Sodium chloride | 13 | 360 | £234 | -56.3% ▼ |
| 13 | 370 | £428 | +18.7% ▲ | |
| 13 | 64 | £196 | -46.2% ▼ | |
| 13 | 416 | £130 | -83.8% ▼ | |
| 13 | 1,100 | £2.4K | +38.3% ▲ | |
| Propantheline bromide | 12 | 1,344 | £1.2K | -7.6% ▼ |
| Enoxaparin | 12 | 336 | £3.4K | -41.5% ▼ |
| Glycopyrronium/formoterol | 12 | 12 | £371 | -52.6% ▼ |
| Frovatriptan | 12 | 144 | £368 | -15.1% ▼ |
| Ofloxacin | 12 | 331 | £398 | +46.0% ▲ |
| Betamethasone sodium phosphate | 12 | 526 | £77 | -2.4% ▼ |
| Other health supplement preparations | 12 | 360 | £133 | -74.7% ▼ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 12 | 124.3K | £1.0K | -80.3% ▼ |
| Timolol and travoprost | 12 | 30 | £104 | -62.9% ▼ |
| Carbomer 974P | 12 | 120 | £51 | +48.2% ▲ |
| Tacrolimus | 12 | 390 | £320 | -77.7% ▼ |
| 12 | 150 | £204 | +36.5% ▲ | |
| 12 | 410 | £1.1K | +43.2% ▲ | |
| 12 | 1,260 | £2.6K | -75.4% ▼ | |
| 12 | 38 | £244 | -56.9% ▼ | |
| 12 | 115 | £604 | +76.9% ▲ | |
| 12 | 49 | £107 | +30.3% ▲ | |
| 12 | 720 | £2.1K | +5.4% ▲ | |
| 12 | 600 | £67 | +79.4% ▲ | |
| Rabeprazole sodium | 11 | 560 | £38 | -78.7% ▼ |
| Midodrine hydrochloride | 11 | 1,110 | £145 | -77.4% ▼ |
| Opicapone | 11 | 330 | £649 | -42.5% ▼ |
| Trihexyphenidyl hydrochloride | 11 | 1,312 | £66 | -61.2% ▼ |
| Procyclidine hydrochloride | 11 | 616 | £29 | -92.2% ▼ |
| Pivmecillinam hydrochloride | 11 | 170 | £87 | -79.1% ▼ |
| Insulin glulisine | 11 | 55 | £308 | -48.7% ▼ |
| Pioglitazone hydrochloride | 11 | 308 | £11 | -87.6% ▼ |
| Triptorelin acetate | 11 | 11 | £675 | -23.3% ▼ |
| Tube feed 1 kcal/ml peptide based (0914041) | 11 | 330.0K | £10.0K | +23.8% ▲ |
| Tars | 11 | 4,950 | £283 | +31.2% ▲ |
| 11 | 1,000 | £14.4K | -48.0% ▼ | |
| 11 | 22 | £107 | -73.0% ▼ | |
| 11 | 1,900 | £168 | +73.0% ▲ | |
| Aclidinium bromide | 10 | 10 | £309 | -62.3% ▼ |
| Reboxetine | 10 | 600 | £168 | -35.1% ▼ |
| Disulfiram | 10 | 280 | £962 | -32.5% ▼ |
| Biphasic insulin lispro | 10 | 150 | £786 | -76.7% ▼ |
| Oestrogens conjugated with progestogen | 10 | 1,008 | £389 | +40.3% ▲ |
| Cabergoline | 10 | 120 | £195 | -35.5% ▼ |
| Combined ethinylestradiol 35mcg | 10 | 630 | £43 | -19.7% ▼ |
| Bicalutamide | 10 | 280 | £14 | -69.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.